Miller R
Curr Neuropharmacol. 2010; 7(4):315-30.
PMID: 20514211
PMC: 2811865.
DOI: 10.2174/157015909790031184.
Miller R
Curr Neuropharmacol. 2010; 7(4):302-14.
PMID: 20514210
PMC: 2811864.
DOI: 10.2174/157015909790031229.
Shioda N, Yamamoto Y, Watanabe M, Binas B, Owada Y, Fukunaga K
J Neurosci. 2010; 30(8):3146-55.
PMID: 20181611
PMC: 6633935.
DOI: 10.1523/JNEUROSCI.4140-09.2010.
Minami M, Hamaue N, Hirafuji M, Saito H, Hiroshige T, Ogata A
J Neural Transm Suppl. 2007; (71):87-95.
PMID: 17447419
PMC: 7120655.
DOI: 10.1007/978-3-211-33328-0_10.
Aosaki T, Kiuchi K, Kawaguchi Y
J Neurosci. 1998; 18(14):5180-90.
PMID: 9651201
PMC: 6793488.
Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie E, deBoer P
J Neurosci. 1997; 17(21):8498-505.
PMID: 9334422
PMC: 6573731.
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.
Markstein R, Gull P, Rudeberg C, Urwyler S, Jaton A, McAllister K
J Neural Transm (Vienna). 1996; 103(3):261-76.
PMID: 8739838
DOI: 10.1007/BF01271238.
Effects of morphine on release of acetylcholine in the rat striatum: an in vivo microdialysis study.
Taguchi K, Hagiwara Y, Suzuki Y, Kubo T
Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(1):9-13.
PMID: 8095326
DOI: 10.1007/BF00168765.
Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.
Zocchi A, Pert A
Psychopharmacology (Berl). 1994; 115(3):297-304.
PMID: 7871068
DOI: 10.1007/BF02245069.
Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.
Wong D, Bymaster F, REID L, Fuller R, Perry K, KORNFELD E
J Neural Transm. 1983; 58(1-2):55-67.
PMID: 6655467
DOI: 10.1007/BF01249124.
SCH 23390 blocks D-1 and D-2 dopamine receptors in rat neostriatum in vitro.
Plantje J, Daus F, Hansen H, Stoof J
Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(2):180-2.
PMID: 6208489
DOI: 10.1007/BF00500914.
Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
de Belleroche J, Gardiner I
J Neural Transm. 1983; 58(3-4):153-68.
PMID: 6141217
DOI: 10.1007/BF01252802.
Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists.
Edvinsson L, McCulloch J, Sharkey J
Br J Pharmacol. 1985; 85(2):403-10.
PMID: 3896363
PMC: 1916598.
DOI: 10.1111/j.1476-5381.1985.tb08875.x.
Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats.
Fuller R, Hemrick-Luecke S
J Neural Transm. 1985; 61(3-4):161-73.
PMID: 3157777
DOI: 10.1007/BF01251910.
Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.
Winkler J, Thermos K, Weiss B
Psychopharmacology (Berl). 1987; 92(3):285-91.
PMID: 2957717
DOI: 10.1007/BF00210832.
Brain dopamine D-2 receptors in senile dementia.
Rinne J, Sako E, Paljarvi L, Molsa P, Rinne U
J Neural Transm. 1986; 65(1):51-62.
PMID: 2870131
DOI: 10.1007/BF01249611.
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
Weiner D, Levey A, Brann M
Proc Natl Acad Sci U S A. 1990; 87(18):7050-4.
PMID: 2402490
PMC: 54680.
DOI: 10.1073/pnas.87.18.7050.
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.
Le Moine C, Normand E, Bloch B
Proc Natl Acad Sci U S A. 1991; 88(10):4205-9.
PMID: 1827915
PMC: 51627.
DOI: 10.1073/pnas.88.10.4205.
Effects of various experimental manipulations on neostriatal acetylcholine and dopamine release.
Lee H, Alcorn L, Weiler M
Neurochem Res. 1991; 16(8):875-83.
PMID: 1787876
DOI: 10.1007/BF00965536.
The putative role of free radicals in the loss of neuronal functioning in senescence.
Joseph J
Integr Physiol Behav Sci. 1992; 27(3):216-27.
PMID: 1419868
DOI: 10.1007/BF02690894.
